ArticleViruses2023

Clinical Efficacy of the Neutralizing Antibody Therapy Sotrovimab in Patients with SARS-CoV-2 Omicron BA.1 and BA.2 Subvariant Infections.

Naoyuki Miyashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.